Diamyd Medical AB (publ) (STO:DMYD.B)
Sweden · Delayed Price · Currency is SEK 1.056
+0.036 (3.53%)
Sep 2, 2026, 5:16 PM CET
Diamyd Medical AB Cash Flow Statement
Financials in millions SEK. Fiscal year is September - August.
Millions SEK. Fiscal year is Sep - Aug.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | May '26 May 31, 2026 | Aug '25 Aug 31, 2025 | Aug '24 Aug 31, 2024 | Aug '23 Aug 31, 2023 | Aug '22 Aug 31, 2022 | Aug '21 Aug 31, 2021 |
Net Income | -283.65 | -169.78 | -151.85 | -116.07 | -103.52 | 60.05 |
Depreciation & Amortization | 6.94 | 6.5 | 5.58 | 4.87 | 4.38 | 0.78 |
Asset Writedown & Restructuring Costs | - | - | 5.41 | - | - | - |
Other Operating Activities | 77.58 | -5.53 | 3.77 | 1.69 | -11.61 | -145.64 |
Change in Accounts Receivable | 0.01 | 0.02 | 0.04 | 0.07 | 10.1 | -19.57 |
Change in Accounts Payable | -5.88 | -4.64 | 11.72 | - | - | - |
Change in Other Net Operating Assets | 14.16 | 3.74 | -3.85 | -1.51 | 7.43 | -5.1 |
Operating Cash Flow | -190.85 | -169.68 | -129.18 | -110.96 | -93.22 | -109.47 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | May '26 May 31, 2026 | Aug '25 Aug 31, 2025 | Aug '24 Aug 31, 2024 | Aug '23 Aug 31, 2023 | Aug '22 Aug 31, 2022 | Aug '21 Aug 31, 2021 |
Capital Expenditures | -3.18 | -10.05 | -8.03 | -11.44 | -34.65 | -4.23 |
Investment in Securities | -39.17 | 27.22 | -19.97 | 39.84 | -39.91 | -7.66 |
Other Investing Activities | -0.18 | - | -0 | - | 6.65 | 144.41 |
Investing Cash Flow | -42.53 | 17.17 | -27.99 | 28.4 | -76.72 | 132.53 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | May '26 May 31, 2026 | Aug '25 Aug 31, 2025 | Aug '24 Aug 31, 2024 | Aug '23 Aug 31, 2023 | Aug '22 Aug 31, 2022 | Aug '21 Aug 31, 2021 |
Issuance of Common Stock | 233.25 | 315.39 | 135.21 | 75.27 | 150 | 60 |
Other Financing Activities | -9.51 | 0.93 | 7.08 | 11.27 | -7.85 | -3.28 |
Financing Cash Flow | 223.74 | 316.32 | 142.28 | 86.54 | 142.16 | 56.72 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | May '26 May 31, 2026 | Aug '25 Aug 31, 2025 | Aug '24 Aug 31, 2024 | Aug '23 Aug 31, 2023 | Aug '22 Aug 31, 2022 | Aug '21 Aug 31, 2021 |
Foreign Exchange Rate Adjustments | -3.13 | 0.62 | 0.12 | 3.79 | 8.17 | 1.22 |
Miscellaneous Cash Flow Adjustments | - | - | - | - | - | -0 |
Net Cash Flow | -12.77 | 164.43 | -14.78 | 7.77 | -19.62 | 81.01 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | May '26 May 31, 2026 | Aug '25 Aug 31, 2025 | Aug '24 Aug 31, 2024 | Aug '23 Aug 31, 2023 | Aug '22 Aug 31, 2022 | Aug '21 Aug 31, 2021 |
Free Cash Flow | -194.03 | -179.73 | -137.21 | -122.4 | -127.87 | -113.69 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | -44913.19% | -138254.61% | -105543.08% | -22418.32% | -28165.42% | -44937.94% |
Free Cash Flow Per Share | -1.38 | -1.60 | -1.45 | -1.56 | -1.67 | -1.63 |
Levered Free Cash Flow | -169.01 | -119.05 | -87.83 | -80.42 | -82.04 | -82.18 |
Unlevered Free Cash Flow | -168.06 | -119.05 | -87.82 | -80.42 | -81.88 | -81.9 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | May '26 May 31, 2026 | Aug '25 Aug 31, 2025 | Aug '24 Aug 31, 2024 | Aug '23 Aug 31, 2023 | Aug '22 Aug 31, 2022 | Aug '21 Aug 31, 2021 |
Cash Interest Paid | 3.57 | 2.63 | 0.01 | 0 | 0.25 | 0.07 |
Change in Working Capital | 8.28 | -0.88 | 7.91 | -1.45 | 17.52 | -24.66 |